Business · 03/03/1994Updated: 10/15/2026 · 1 min read
Determination of Regulatory Review Period for Purposes of Patent Extension; Imagent GI
Summary
The Food and Drug Administration (FDA) has determined the regulatory review period for Imagent GI and published a notice of that determination as required by law.
Original source language: Federal Register — Health and Human ServicesOpen original release →